ArticleAmerican journal of cancer research2025
Risk factors for immunoresistance in advanced non-small cell lung cancer and the advantages of targeted therapy in improving prognosis.
Ping Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.